Researcher
Philip Vlummens
- Keywords:Hematology, Multiple Myeloma
- Disciplines:Analysis of next-generation sequence data, Hematology, Bioinformatics data integration and network biology
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From8 Nov 2017 → 30 Sep 2018 - Department of Pediatrics and medical genetics (Department)
Member
From1 Oct 2009 → 31 Aug 2011
Projects
1 - 1 of 1
- Identification of new genes for recessive forms of the Ehlers-Danlos syndrome (EDS)From1 Oct 2009 → 30 Sep 2011Funding: BOF - Other initiatives, FWO fellowships
Publications
1 - 10 of 25
- Identifying patients with chronic lymphocytic leukemia without need of treatment : end of endless watch and wait?(2022)
Authors: Christian Brieghel, Veerle Galle, Rudi Agius, Caspar Da Cunha-Bang, Michael A. Andersen, Philip Vlummens, Mattias Mattsson, Richard Rosenquist, Karin E. Smedby, Carmen D. Herling, et al.
Pages: 369 - 378 - Compass : a prospective study comparing clinical evaluation with different geriatric screening methods in newly diagnosed elderly multiple myeloma patients(2021)Volume: 21
Authors: Michel Delforge, Jolien Raddoux, Cindy Kenis, Anneleen Vanhellemont, Philippe Mineur, Ellen Hoornaert, Ka Lung Wu, Jo Caers, Koen Van Eygen, Alain Kentos, et al.
Pages: S124 - S124 - CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma(2021)
Authors: Kim De Veirman, Janik Puttemans, Ahmet Krasniqi, Thomas Ertveldt, Heleen Hanssens, Ema Romao, Dirk Hose, Cleo Goyvaert, Philip Vlummens, Serge Muyldermans, et al.
- Quality of life analyses in patients with multiple myeloma : results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study(2021)
Authors: Gabriel Tremblay, Patrick Daniele, Janis Breeze, Lingling Li, Jatin Shah, Sharon Shacham, Michael Kauffman, Monika Engelhardt, Ajaj Chari, Ajay Nooka, et al.
- Daratumumab With Cetrelimab, an Anti-PD-1 Monoclonal Antibody, in Relapsed/Refractory Multiple Myeloma(2021)
Authors: Yael C. Cohen, Albert Oriol, Ka Lung Wu, Noa Lavi, Philip Vlummens, Carolyn Jackson, Wendy Garvin, Robin Carson, Wendy Crist, Jiayu Fu, et al.
Pages: 46 - + - Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics(2021)
Authors: Simon J. Harrison, Aurore Perrot, Adrian Alegre, David Simpson, Ming Chung Wang, Andrew Spencer, Sosana Delimpasi, Cyrille Hulin, Kazutaka Sunami, Thierry Facon, et al.
Pages: 120 - 131 - Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma(2019)
Authors: Anke Maes, Ken Maes, Philip Vlummens, Hendrik De Raeve, Julie Devin, Vanessa Szablewski, Kim De Veirman, Eline Menu, Jerome Moreaux, Karin Vanderkerken, et al.
- Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis : results of the multicenter HOVON 104 trial(2019)
Authors: Monique C Minnema, Kazem Nasserinejad, Bouke Hazenberg, Ute Hegenbart, Philip Vlummens, Paula F Ypma, Nicolaus Kroeger, Ka Lung Wu, Marie Jose Kersten, M Ron Schaafsma, et al.
Pages: 2274 - 2282 - The exosomal transfer of acid sphingomyelinase contributes to drug resistance in multiple myeloma(2019)Volume: 134
Authors: Inge Oudaert, Sylvia Faict, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens, Lotte Jacobs, Kim De Veirman, Elke De Bruyne, Karel Fostier, et al.
Number of pages: 1 - The anaphase-promoting complex/cyclosome : a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma(2019)
Authors: Anke Maes, Ken Maes, Hendrik De Raeve, Eva De Smedt, Philip Vlummens, Vanessa Szablewski, Julie Devin, Sylvia Faict, Kim De Veirman, Eline Menu, et al.
Pages: 1137 - 1146